What is HBOT stem cell therapy for cerebral palsy? Hyperbaric Oxygen Therapy (HBOT) triggers the patient’s own bone marrow to release CD34+ stem cells into the bloodstream. After 40 cumulative hours of HBOT, these cells travel to injured brain tissue — facilitating neural repair, improving motor function, and reducing CP symptoms with zero rejection risk, because the cells come from the patient’s own body.
What is Cerebral Palsy?
Cerebral palsy (CP) is a group of conditions that result from injuries or abnormalities of the brain, most often occurring in the womb but possible at any point during the first two years after birth. It affects brain and nervous system functions including movement, muscle control, coordination, thinking, seeing, hearing, and learning.
An estimated 764,000 children and adults in the United States have one or more symptoms of CP, making it the most common motor disability of childhood. Despite its prevalence, current medical treatments remain largely supportive rather than curative.
Common Causes of Cerebral Palsy
Hypoxia (low oxygen to the brain) — Oxygen deprivation during birth or in the womb, damaging developing brain tissue
Head injury — Trauma to the head during or shortly after birth
Maternal infections — Infections during pregnancy, such as rubella, affecting fetal brain development
Brain bleeding or hemorrhage — Intracranial bleeding that disrupts normal brain structure
Brain infection or severe jaundice — Postnatal conditions causing neurological damage in the critical development window
Types of Cerebral Palsy
Cerebral palsy is classified into five main types based on the nature of movement difficulties present:
- Spastic CP: The most common type — characterized by stiff, tight muscles and awkward movement
- Dyskinetic CP: Uncontrolled, involuntary movements affecting the hands, arms, feet, and legs
- Ataxic CP: Affects balance and coordination — patients may appear unsteady or shaky
- Hypotonic CP: Decreased muscle tone resulting in a “floppy” appearance and reduced movement
- Mixed CP: A combination of two or more types, most commonly spastic and dyskinetic
Can Stem Cell Therapy Help Children with Cerebral Palsy?
Yes — and the evidence is growing. According to Duke University, which is conducting ongoing clinical trials using autologous (patient’s own) cord blood-derived stem cells to treat children with cerebral palsy, functional improvement has been reported in participating patients.
At Hyperbaric Centers of Florida, we use a non-invasive alternative: instead of cord blood infusion, we use HBOT to mobilize the patient’s own CD34+ stem cells from bone marrow — achieving a similar therapeutic goal without injections, without banking, and with zero rejection risk.
How HBOT Mobilizes Stem Cells for Brain Repair
The University of Pennsylvania School of Medicine’s Stem Cell Mobilization Study proved that HBOT reliably mobilizes CD34+ stem cells from the bone marrow after 40 cumulative hours of oxygen exposure. This is the scientific foundation for our CP treatment protocol.
Here is how the process works at the cellular level:
CD34+ Stem Cell Release from Bone Marrow
After 40 hours of HBOT exposure, bone marrow releases cascades of CD34+ stem cells into the bloodstream. These cells are naturally keyed to the patient’s own DNA — no rejection risk, no donor matching required.
Neural Cell Engraftment & Repair
CD34+ stem cells engraft in brain tissue and differentiate into neural cells, facilitating repair of the damaged brain regions responsible for movement, cognition, and sensory processing in CP patients.
1000% Oxygen Saturation in Tissues
Under HBOT pressure, oxygen dissolves into plasma — flooding tissues that blood vessels cannot normally reach. This oxygen-rich environment dramatically accelerates cellular healing and stem cell activity.
Reduces Neuroinflammation
HBOT significantly reduces systemic and neurological inflammation — one of the primary drivers of ongoing functional limitation in children with cerebral palsy.
Promotes New Blood Vessel Formation
Pressurized oxygen stimulates angiogenesis in the brain, improving circulation to damaged regions and supporting long-term neurological recovery.
Why autologous stem cells matter: HBOT mobilizes cells from the patient’s own bone marrow — their DNA, their body. This eliminates all rejection risk that comes with donor stem cell transplants, making HBOT-assisted mobilization a uniquely safe approach for pediatric patients.
Which types of stem cells are best to treat CP and how are they obtained?
The CD 34+ stem cells are ideally suited for the treatment of Autism. HBOT exposure causes the bone marrow to mobilize cascades of CD 34+ stem cells from the patient’s own body. Naturally, these cells are keyed with the patient’s own DNA, therefore these stem cells pose no rejection risk because the body does not recognize them as foreign.
We offer one protocol to mobilize the CD 34+ stem cells for CP:
two 60-minute hyperbaric exposures daily for 20 consecutive days (each exposure is for approximately 75-minutes in total duration)
* It is suggested that the parent/caregiver read theUniversity of Pennsylvania School of Medicine “Stem Cell Mobilization Study”. Please click here for copy of full study to understand how Hyperbaric Oxygen Therapy (HBOT) has been proven to mobilize CD 34+ stem cells after 40 cumulative hours of exposure.
